Long term prognosis of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease
CONCLUSION: Triple combination therapy in the induction phase can reduce the risk of recurrence and facilitate drug withdrawal in anti-MDA5-positive DM-ILD.PMID:37714541 | DOI:10.3899/jrheum.2023-0371
Source: J Rheumatol - Category: Rheumatology Authors: Tsuneo Sasai Ran Nakashima Hideaki Tsuji Toshiki Nakajima Yoshitaka Imura Yusuke Yoshida Shintaro Hirata Mirei Shirakashi Ryosuke Hiwa Koji Kitagori Shuji Akizuki Hajime Yoshifuji Tsuneyo Mimori Akio Morinobu Source Type: research
More News: Clinical Trials | Dermatology | Dermatomyositis | Genetics | Interstitial Lung Disease | Melanoma | Rheumatology | Skin Cancer | Study